missing translation for 'onlineSavingsMsg'
Learn More

Altiratinib, MedChemExpress

Product Code. 16488456
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16488456 100 mg 100mg
16454487 50 mg 50mg
16431068 5 mg 5mg
16418618 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16488456 Supplier Medchem Express Supplier No. HYB0791

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Altiratinib (DCC-2701) is a multi-targeted kinase inhibitor with IC50s of 2.7, 8, 9.2, 9.3, 0.85, 4.6, 0.83 nM for MET, TIE2, VEGFR2, FLT3, Trk1, Trk2, and Trk3 respectively.

Altiratinib (DCC-2701) is a multi-targeted kinase inhibitor with IC50s of 2.7, 8, 9.2, 9.3, 0.85, 4.6, 0.83 nM for MET, TIE2, VEGFR2, FLT3, Trk1, Trk2, and Trk3 respectively.

Specifications

Chemical Name or Material Altiratinib
CAS 1345847-93-9
Color Khaki
Purity Grade Notes Research
Molecular Formula C26H21F3N4O4
Quantity 100 mg
Synonym DCC-2701
Solubility Information DMSO : 25 mg/mL (48.98 mM; Need ultrasonic)
SMILES O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC(F)=C(OC4=CC(NC(C5CC5)=O)=NC=C4)C=C3F
Molecular Weight (g/mol) 510.46
Formula Weight 510.46
Percent Purity 98.06%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.